Announcement of a podium presentation at a prestigious symposium, showcasing innovative research in cell therapy for type 1 diabetes. Presentation features promising clinical data on UP421, a novel ...
Sana is Incorporating the Tested Immune Evasion Technology to Develop SC451, a HIP-modified, Stem Cell-Derived Therapy as a One-Time Treatment for Patients with Type 1 Diabetes, with a Goal of Normal ...
Medical biotechnology harnesses advanced molecular tools and biological systems to develop innovative diagnostic modalities, targeted therapies, and preventive measures. Built on decades of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results